Trials / Completed
CompletedNCT00202605
Safety and Efficacy of SPD465 in Adults With ADHD
A Phase II, Randomized, Double-Blind, Multi-center, Placebo-controlled, Crossover Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 72 (planned)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate how safe and how well SPD465 works compared to placebo in adults with ADHD. It is hypothesized that SPD465 will achieve an extended duration of clinical benefit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Neutral salts of dextroamphetamine sulfate, USP, amphetamine sulfate, USP, d-amphetamine saccharate, d,I-amphetamine aspartate monohydrate |
Timeline
- Start date
- 2005-09-29
- Primary completion
- 2006-01-06
- Completion
- 2006-01-06
- First posted
- 2005-09-20
- Last updated
- 2021-06-24
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00202605. Inclusion in this directory is not an endorsement.